1 |
BRABYN P, CAPOTE A, BELLOTI M, et al. Hyperparathyroidism diagnosed due to brown tumors of the jaw: a case report and literature review[J]. J Oral Maxillofac Surg, 2017, 75(10): 2162-2169.
|
2 |
DAWOOD N B, YAN K L, SHIEH A, et al. Normocalcaemic primary hyperparathyroidism: an update on diagnostic and management challenges[J]. Clin Endocrinol, 2020, 93(5): 519-527.
|
3 |
SEIB C D, MENG T, SUH I, et al. Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines[J]. Surgery, 2021, 169(1): 87-93.
|
4 |
CUOMO D, PORRECA I, COBELLIS G, et al. Carcinogenic risk and Bisphenol A exposure: a focus on molecular aspects in endoderm derived glands[J]. Mol Cell Endocrinol, 2017, 457: 20-34.
|
5 |
JEONG C, KWON H I, BAEK H, et al. Association of hyperparathyroidism and papillary thyroid cancer: a multicenter retrospective study[J]. Endocrinol Metab Seoul Korea, 2020, 35(4): 925-932.
|
6 |
戴 威, 卢林捷, 孔令泉, 等. 甲状旁腺功能亢进症合并甲状腺乳头状癌三例报道[J]. 中华内分泌外科杂志, 2017(1): 86-87.
|
7 |
PAPADAKIS M, WEYERBROCK N, ZIRNGIBL H, et al. Correlation of perioperative biochemical variables with single adenoma weight in patients with primary hyperparathyroidism[J]. BMC Surg, 2020, 20(1): 303.
|
8 |
SINGH OSPINA N M, RODRIGUEZ-GUTIERREZ R, MARAKA S, et al. Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis[J]. World J Surg, 2016, 40(10): 2359-2377.
|
9 |
代文杰, 喻庆安. 原发性甲状旁腺功能亢进症围手术期处理中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(6): 634-638.
|
10 |
CHARLES P Y, LETAVERNIER E, PERIE S, et al. Effect of parathyroidectomy on renal stone recurrence[J]. Urolithiasis, 2021,49(4):327-334.
|
11 |
OLSON J A, LEIGHT G S. Surgical management of secondary hyperparathyroidism[J]. Adv Ren Replace Ther, 2002, 9(3): 209-218.
|
12 |
PATEL A, LEE C Y, SLOAN D A, et al. Parathyroidectomy for tertiary hyperparathyroidism: a multi-institutional analysis of outcomes[J]. J Surg Res, 2021, 258: 430-434.
|
13 |
张 翔, 胡 亚, 王梦一, 等. 原发性甲状旁腺功能亢进症的术前诊断与外科治疗策略[J]. 中华内分泌外科杂志, 2018, 12(4): 274-277.
|
14 |
王鸿程, 陈 炯. 原发性甲状旁腺功能亢进的诊断及治疗[J]. 中国临床新医学, 2019, 12(3): 252-255.
|
15 |
LI J, ZHANG Y Y, et al. Primary hyperparathyroidism with nausea and vomiting as its first symptom: case report and literature review[J].Med Diagn, 2019, 9(1): 12-16.
|
16 |
PANDIYAN B, MERRILL S J. A model of the cost of delaying treatment of Hashimotos thyroiditis: thyroid cancer initiation and growth[J]. Math Biosci Eng, 2019, 16(6): 8069-8091.
|
17 |
SHEN J, WU Q, WANG Y. The role of ultrasound in the diagnosis of the coexistence of primary hyperparathyroidism and non-medullary thyroid carcinoma[J]. BMC Med Imaging, 2019, 19(1):7.
|
18 |
崔 铭, 王 鸥, 廖 泉. 原发性甲状旁腺功能亢进症诊断及手术治疗进展[J]. 协和医学杂志, 2020,11(4): 395-401
|
19 |
HELBROW J, OWAIS A E, SIDWELL A G, et al. The use of intraoperative parathyroid hormone monitoring in minimally invasive parathyroid surgery[J]. Ann R Coll Surg Engl, 2016,98(7):516-519.
|
20 |
闫桂玲, 胡 薇, 吴育寿, 等. 甲状腺切除术后甲状旁腺功能减退的主要影响因素分析[J]. 第二军医大学学报, 2017, 38(10): 1267-1272.
|